These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 143666)

  • 1. The HLA system and survival in malignant disease: Hodgkin's disease and carcinoma of the breast.
    Falk J; Osoba D
    Prog Clin Biol Res; 1977; 16():205-19. PubMed ID: 143666
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.
    Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C
    Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456
    [No Abstract]   [Full Text] [Related]  

  • 3. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP; Petrányi G; Hollán Z
    Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA and MLC typing in patients with Hodgkin's disease.
    Hansen JA; Young CW; Whitsett C; Case DC; Jersild C; Good RA; Dupont B
    Prog Clin Biol Res; 1977; 16():217-27. PubMed ID: 143667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of HLA antigen system investigation in children with malignant lymphoreticular diseases].
    Vuković I; Janković M; Susaković N; Gligorović V
    Bilt Hematol Transfuz; 1979; 7(1 Suppl):13-22. PubMed ID: 298833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of the HL-A system and the association with malignant lymphomas.
    van den Tweel JG; Dugas DJ; Loon J
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):732-5. PubMed ID: 495572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of HLA antigens to prognosis in Hodgkin's disease].
    Prazák J; Chytrý P; Hermanská Z
    Vnitr Lek; 1991; 37(9-10):781-8. PubMed ID: 1771812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukaemia antigens: mixed leucocyte culture tests on twelve leukaemic patients with identical twins.
    Fefer A; Mickelson E; Thomas ED
    Clin Exp Immunol; 1974 Oct; 18(2):237-42. PubMed ID: 4283118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological aspects of malignant disease.
    Oliver RT
    Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells].
    Marmont A
    Minerva Med; 1978 Apr; 69(18):1263-74. PubMed ID: 351459
    [No Abstract]   [Full Text] [Related]  

  • 12. [HLA antigens and susceptibility to disease].
    Bertrams J
    Dtsch Med Wochenschr; 1976 Jan; 101(5):178-84. PubMed ID: 1061667
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HL-A antigens in haematological malignant diseases.
    Jeannet M; Magnin C
    Eur J Clin Invest; 1971 Nov; 2(1):39-42. PubMed ID: 5290218
    [No Abstract]   [Full Text] [Related]  

  • 15. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.
    Cohen E; Singal DP; Khurana U; Gregory SG; Cox C; Sinks L; Henderson E; Fitzpatrick JE; Higby D
    Prog Clin Biol Res; 1977; 16():65-70. PubMed ID: 269457
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic response in patients to cells of their own tumor.
    Albert Z; Harlozińska A; Richter R; Salwa J; Singer Z
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):455-63. PubMed ID: 4328728
    [No Abstract]   [Full Text] [Related]  

  • 18. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
    Engleman EG; Benike C; Hoppe RT; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.